SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.97-1.6%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Courtney Willfore who wrote (11118)11/15/1997 9:56:00 AM
From: Henry Niman  Read Replies (2) of 32384
 
CW, I really see LGND quite positively. Others have criticized their burn rate, but their $200 million deal with LLY should taken them through profitability in 1999. Others have also complained about share dilution, but I view that as a necessary evil required to take LGND into the fully integrated pharmaceutical category. Many, including LGND management, consider LGND's pipeline the best in the sector, and I whole-heartedly agree.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext